10-Q – Page 69 – China Stock Advice

CBPO [China Biologic Products] 10-Q: (Original Filing)

[] [STATE OF DELAWARE THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CHINA BIOLOGIC PRODUCTS, INC. Corporation China Biologic Products, Inc., a corporation organized and existing under the laws of the State of Delaware (the “ The name of the Corporation is China Biologic Products, Inc. The original Certificate of Incorporation of the Corporation was filed with the Secretary of State] [Settlement Agreement This settlement agreement (this “Agreement”) was entered into by and among the following parties (the “Parties,” and each a “Party”) in Yunyan District, Guiyang City, China on July 31, 2016: Party A: Guizhou Taibang Biological Products Co., Ltd. Party B: Guiyang Dalin Biologic Technologies Co., Ltd. Party C: Guizhou Jie’an Company Party D: Shenzhen Yigong Shengda Technology Co.,] [Guarantee Agreement This Guarantee Agreement (this “Agreement”) was entered into by the following parties (the “Parties,” and each a “Party”) at No.808 Meeting Room No. 3 Office Building of Guizhou Province Government in Guiyang City, China on July 31, 2016: Party A: Guizhou Taibang Biological Products Co., Ltd. (“Guizhou Taibang”) Party B: Guiyang Dalin Biologic Technologies Co., Ltd. (“Guiyang Dalin”)] [CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (this “Agreement”) is entered into as of this July 1, 2016 (the “Effective Date”) by and between CHINA BIOLOGIC PRODUCTS, INC., a Delaware corporation (the “Company”) and Mr. Hui (David) Li (hereinafter referred to as the “Consultant”). WHEREAS, NOW, THEREFORE, Senior Strategic and Investment Consulting Agreement 1. provided however Term 2. Compensation 3. (c) Consultant] [Second Amended and Restated Employment Agreement Agreement Company Executive This Second Amended and Restated Employment Agreement (this “ 2012 Agreement WHEREAS, the Company and the Executive entered into an employment agreement dated as of May 11, 2012 (the “ 2014 Agreement WHEREAS, the Company and the Executive entered into a renewal employment agreement dated as of May 11, 2014 (the] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th David (Xiaoying) Gao Chief Executive Officer] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang (Principal Financial and Accounting Officer) Chief Financial Officer]

By info| 2016-08-05T02:57:03+00:00 August 4th, 2016|Categories: CBPO, Chinese Stocks, SEC Original|Tags: 0001369868, 10-Q, 2016-08-04, 2836, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

CBPO [China Biologic Products] 10-Q:

[] [STATE OF DELAWARE THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CHINA BIOLOGIC PRODUCTS, INC. Corporation China Biologic Products, Inc., a corporation organized and existing under the laws of the State of Delaware (the “ The name of the Corporation is China Biologic Products, Inc. The original Certificate of Incorporation of the Corporation was filed with the Secretary of State] [Settlement Agreement This settlement agreement (this “Agreement”) was entered into by and among the following parties (the “Parties,” and each a “Party”) in Yunyan District, Guiyang City, China on July 31, 2016: Party A: Guizhou Taibang Biological Products Co., Ltd. Party B: Guiyang Dalin Biologic Technologies Co., Ltd. Party C: Guizhou Jie’an Company Party D: Shenzhen Yigong Shengda Technology Co.,] [Guarantee Agreement This Guarantee Agreement (this “Agreement”) was entered into by the following parties (the “Parties,” and each a “Party”) at No.808 Meeting Room No. 3 Office Building of Guizhou Province Government in Guiyang City, China on July 31, 2016: Party A: Guizhou Taibang Biological Products Co., Ltd. (“Guizhou Taibang”) Party B: Guiyang Dalin Biologic Technologies Co., Ltd. (“Guiyang Dalin”)] [CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (this “Agreement”) is entered into as of this July 1, 2016 (the “Effective Date”) by and between CHINA BIOLOGIC PRODUCTS, INC., a Delaware corporation (the “Company”) and Mr. Hui (David) Li (hereinafter referred to as the “Consultant”). WHEREAS, NOW, THEREFORE, Senior Strategic and Investment Consulting Agreement 1. provided however Term 2. Compensation 3. (c) Consultant] [Second Amended and Restated Employment Agreement Agreement Company Executive This Second Amended and Restated Employment Agreement (this “ 2012 Agreement WHEREAS, the Company and the Executive entered into an employment agreement dated as of May 11, 2012 (the “ 2014 Agreement WHEREAS, the Company and the Executive entered into a renewal employment agreement dated as of May 11, 2014 (the] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th David (Xiaoying) Gao Chief Executive Officer] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang (Principal Financial and Accounting Officer) Chief Financial Officer]

By info| 2016-08-05T02:57:50+00:00 August 4th, 2016|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: 0001369868, 10-Q, 2016-08-04, 2836, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

AMC [AMC ENTERTAINMENT] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) ☒ For the quarterly period ended June 30, 2016 OR ☐ For the transition period from to ‑33892 AMC ENTERTAINMENT HOLDINGS, INC. Delaware (State or other jurisdiction of incorporation or organization) 26 ‑0303916 (I.R.S. Employer Identification No.) One AMC Way 11500 Ash Street, Leawood, KS 66211 (Zip Code) (913) 213 ‑2000 ☒ No ☐ ☒ No] [CERTIFICATIONS I, Adam M. Aron, certify that: 1. I have reviewed this quarterly report on Form 10 ‑Q of AMC Entertainment Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATIONS I, Craig R. Ramsey, certify that: 1. I have reviewed this quarterly report on Form 10 ‑Q of AMC Entertainment Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATION OF PERIODIC REPORT ‑Oxley Act of 2002, 18 U.S.C. Section 1350, that: (1) the Quarterly Report on Form 10 ‑Q of the Company for the quarter ended June 30 (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 1 , 2016 Adam M.]

By info| 2016-08-02T11:33:38+00:00 August 1st, 2016|Categories: AMC, Chinese Stocks, SEC Original|Tags: 0001411579, 10-Q, 2016-08-01, 7830, AMC, SERVICES-MOTION PICTURE THEATERS|0 Comments

AMC [AMC ENTERTAINMENT] 10-Q: FORM 10-Q (Mark One) ☒ For the quarterly

[FORM 10-Q (Mark One) ☒ For the quarterly period ended June 30, 2016 OR ☐ For the transition period from to ‑33892 AMC ENTERTAINMENT HOLDINGS, INC. Delaware (State or other jurisdiction of incorporation or organization) 26 ‑0303916 (I.R.S. Employer Identification No.) One AMC Way 11500 Ash Street, Leawood, KS 66211 (Zip Code) (913) 213 ‑2000 ☒ No ☐ ☒ No] [CERTIFICATIONS I, Adam M. Aron, certify that: 1. I have reviewed this quarterly report on Form 10 ‑Q of AMC Entertainment Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATIONS I, Craig R. Ramsey, certify that: 1. I have reviewed this quarterly report on Form 10 ‑Q of AMC Entertainment Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATION OF PERIODIC REPORT ‑Oxley Act of 2002, 18 U.S.C. Section 1350, that: (1) the Quarterly Report on Form 10 ‑Q of the Company for the quarter ended June 30 (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 1 , 2016 Adam M.]

By info| 2016-08-02T11:34:27+00:00 August 1st, 2016|Categories: AMC, Chinese Stocks, Webplus ver|Tags: 0001411579, 10-Q, 2016-08-01, 7830, AMC, SERVICES-MOTION PICTURE THEATERS|0 Comments

LEDS [SemiLEDs] 10-Q: (Original Filing)

[FORM 10-Q ☒ For the quarterly period ended May 31, 2016 or ☐ For the transition period from to SemiLEDs Corporation Delaware 20-2735523 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) 3F, No. 11 Ke Jung Rd., Chu-Nan Site, Hsinchu Science Park, Chu-Nan 350, Miao-Li County, Taiwan, R.O.C. 350 (Zip Code) +886-37-586788 ☒ No ☐ ☒] [1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Trung Tri Doan, certify that: 1. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [CERTIFICATION OF CHIEF FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Christopher Lee , certify that: 1. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not] [CERTIFICATION SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 May 31 , 201 6 (1) (2) Dated: July 13 , 201 6 Chairman and Chief Executive Officer EX-32.1 4 leds-20160531ex3215eadff.htm EX-32.1] [CERTIFICATION SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Q for the quarter ended May 31 , 201 6 Christopher Lee (1) (2) Dated: July 13 , 201 6 Christopher Lee Christopher Lee Chief Financial Officer EX-32.2 5 leds-20160531ex322a0b5b4.htm EX-32.2]

By info| 2016-07-14T15:24:20+00:00 July 13th, 2016|Categories: Chinese Stocks, LEDS, SEC Original|Tags: 0001333822, 10-Q, 2016-07-13, 3674, LEDS, SEMICONDUCTORS and RELATED DEVICES|0 Comments

LEDS [SemiLEDs] 10-Q: FORM 10-Q ☒ For the quarterly period ended

[FORM 10-Q ☒ For the quarterly period ended May 31, 2016 or ☐ For the transition period from to SemiLEDs Corporation Delaware 20-2735523 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) 3F, No. 11 Ke Jung Rd., Chu-Nan Site, Hsinchu Science Park, Chu-Nan 350, Miao-Li County, Taiwan, R.O.C. 350 (Zip Code) +886-37-586788 ☒ No ☐ ☒] [1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Trung Tri Doan, certify that: 1. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [CERTIFICATION OF CHIEF FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Christopher Lee , certify that: 1. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not] [CERTIFICATION SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 May 31 , 201 6 (1) (2) Dated: July 13 , 201 6 Chairman and Chief Executive Officer EX-32.1 4 leds-20160531ex3215eadff.htm EX-32.1] [CERTIFICATION SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Q for the quarter ended May 31 , 201 6 Christopher Lee (1) (2) Dated: July 13 , 201 6 Christopher Lee Christopher Lee Chief Financial Officer EX-32.2 5 leds-20160531ex322a0b5b4.htm EX-32.2]

By info| 2016-07-14T15:25:07+00:00 July 13th, 2016|Categories: Chinese Stocks, LEDS, Webplus ver|Tags: 0001333822, 10-Q, 2016-07-13, 3674, LEDS, SEMICONDUCTORS and RELATED DEVICES|0 Comments

SCOK [Hongli Clean Energy Technologies] 10-Q: (Original Filing)

[] [Transferor (“Party A”): Henan Pingdingshan Hongli Coal and Coking Co., Ltd. (“Hongli”) and its branch Baofeng Coking Factory of Henan Pingdingshan Hongli Coal and Coking Co., Ltd. (“Baofeng Coking”) Transferee (“ Party B”): Pingdingshan Hongfeng Coal Processing and Coking Factory (“Hongfeng”) Considering that: Considering that: Party A and Party B have checked every asset on the basis of data preliminarily] [I, Jianhua Lv, certify that: (1) I have reviewed this Form 10-Q of Hongli Clean Energy Technologies Corp.; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not] [Certification of Principal Financial Officer I, Song Lv, certify that: (1) I have reviewed this Form 10-Q of Hongli Clean Energy Technologies Corp.; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Hongli Clean Energy Technologies Corp. Jianhua Lv] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Hongli Clean Energy Technologies Corp. Song Lv Chief Financial Officer (Principal Financial Officer)] [Intermediate People's Court of Zhengzhou Henan Civil Judgment (2015) ZMECZ No. 96 The plaintiff, Henan Pingdingshan Hongli Coal & Coking Co., Ltd., located in the intersection of Kuanggong Road and Tiyu Road in Xinhua District, Pingdingshan City. The legal representative, Lv Jianhua, the company chairman. The entrusted agent, Wang Dan, lawyer of Henan Tianji Law Firm. The entrusted agent, Li]

By info| 2016-05-24T04:29:02+00:00 May 23rd, 2016|Categories: Chinese Stocks, SCOK, SEC Original|Tags: 0001099290, 10-Q, 2016-05-23, 3312, SCOK, STEEL WORKS, BLAST FURNACES ROLLING MILLS (COKE OVENS)|0 Comments

SCOK [Hongli Clean Energy Technologies] 10-Q:

[] [Transferor (“Party A”): Henan Pingdingshan Hongli Coal and Coking Co., Ltd. (“Hongli”) and its branch Baofeng Coking Factory of Henan Pingdingshan Hongli Coal and Coking Co., Ltd. (“Baofeng Coking”) Transferee (“ Party B”): Pingdingshan Hongfeng Coal Processing and Coking Factory (“Hongfeng”) Considering that: Considering that: Party A and Party B have checked every asset on the basis of data preliminarily] [I, Jianhua Lv, certify that: (1) I have reviewed this Form 10-Q of Hongli Clean Energy Technologies Corp.; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not] [Certification of Principal Financial Officer I, Song Lv, certify that: (1) I have reviewed this Form 10-Q of Hongli Clean Energy Technologies Corp.; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Hongli Clean Energy Technologies Corp. Jianhua Lv] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Hongli Clean Energy Technologies Corp. Song Lv Chief Financial Officer (Principal Financial Officer)] [Intermediate People's Court of Zhengzhou Henan Civil Judgment (2015) ZMECZ No. 96 The plaintiff, Henan Pingdingshan Hongli Coal & Coking Co., Ltd., located in the intersection of Kuanggong Road and Tiyu Road in Xinhua District, Pingdingshan City. The legal representative, Lv Jianhua, the company chairman. The entrusted agent, Wang Dan, lawyer of Henan Tianji Law Firm. The entrusted agent, Li]

By info| 2016-05-24T04:30:07+00:00 May 23rd, 2016|Categories: Chinese Stocks, SCOK, Webplus ver|Tags: 0001099290, 10-Q, 2016-05-23, 3312, SCOK, STEEL WORKS, BLAST FURNACES ROLLING MILLS (COKE OVENS)|0 Comments

BSPM [Biostar Pharmaceuticals] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) ☒ March 31, 2016 For the quarterly period ended: Or ☐ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Ronghua Wang EX-32.1 4 ex32-1.htm EX-32.1] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Qinghua Liu Qinghua Liu Interim Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm EX-32.2]

By info| 2016-05-24T03:41:41+00:00 May 23rd, 2016|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 10-Q, 2016-05-23, 2834, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals] 10-Q: FORM 10-Q (Mark One) ☒ March 31, 2016

[FORM 10-Q (Mark One) ☒ March 31, 2016 For the quarterly period ended: Or ☐ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Ronghua Wang EX-32.1 4 ex32-1.htm EX-32.1] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Qinghua Liu Qinghua Liu Interim Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm EX-32.2]

By info| 2016-05-24T03:43:19+00:00 May 23rd, 2016|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 10-Q, 2016-05-23, 2834, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments